New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
A predictive biomarker of response to therapy in patients with microsatellite stable metastatic colorectal cancer

A predictive biomarker of response to therapy in patients with microsatellite stable metastatic colorectal cancer

by Vall d'Hebron Institute of OncologyA total of 166 patients with mCRCBRAF-V600Ewere included in the study from discovery (n = 46), validation (n = 52) and control (n = 68) cohorts. WES of
Oncology January 08,2024
A predictive biomarker of response to therapy in patients with microsatellite stable metastatic colorectal cancer

A predictive biomarker of response to therapy in patients with microsatellite stable metastatic colorectal cancer

by Vall d'Hebron Institute of OncologyA total of 166 patients with mCRCBRAF-V600Ewere included in the study from discovery (n = 46), validation (n = 52) and control (n = 68) cohorts. WES of
Oncology January 08,2024
Microbiome: Scientists highlight role of harmful gut bacteria in fever afflicting cancer patients

Microbiome: Scientists highlight role of harmful gut bacteria in fever afflicting cancer patients

by Delthia Ricks , Medical XpressSchematic of histological quantification of the dense inner colonic mucus layer histologically, following PAS staining. Eight equally radially spaced sites are identif
Oncology January 08,2024
Microbiome: Scientists highlight role of harmful gut bacteria in fever afflicting cancer patients

Microbiome: Scientists highlight role of harmful gut bacteria in fever afflicting cancer patients

by Delthia Ricks , Medical XpressSchematic of histological quantification of the dense inner colonic mucus layer histologically, following PAS staining. Eight equally radially spaced sites are identif
Oncology January 08,2024
Microbubbles could help bowel cancer patients avoid life-changing surgeries

Microbubbles could help bowel cancer patients avoid life-changing surgeries

byUniversity of Strathclyde, Glasgow(a) KPN [13,14] or WT organoids were generated from KPN or C57BL6/J mice, respectively, and were injected into the hind leg of C57BL6/J mice. Animals injected
Oncology January 08,2024
Microbubbles could help bowel cancer patients avoid life-changing surgeries

Microbubbles could help bowel cancer patients avoid life-changing surgeries

byUniversity of Strathclyde, Glasgow(a) KPN [13,14] or WT organoids were generated from KPN or C57BL6/J mice, respectively, and were injected into the hind leg of C57BL6/J mice. Animals injected
Oncology January 08,2024
Microdosed incisional clindamycin cuts SSI after skin cancer surgery

Microdosed incisional clindamycin cuts SSI after skin cancer surgery

by Elana GotkineFor patients undergoing skin cancer surgery, microdosed incisional clindamycin reduces the rate of surgical site infections (SSIs), according to a study published online May 24 in&nbsp
Oncology January 08,2024
Microdosed incisional clindamycin cuts SSI after skin cancer surgery

Microdosed incisional clindamycin cuts SSI after skin cancer surgery

by Elana GotkineFor patients undergoing skin cancer surgery, microdosed incisional clindamycin reduces the rate of surgical site infections (SSIs), according to a study published online May 24 in&nbsp
Oncology January 08,2024
Microcalcification 'fingerprints' can yield info about cancer

Microcalcification 'fingerprints' can yield info about cancer

byCornell UniversityLeft, a pathology stain of a ductal carcinoma, showing cells and connective tissue. Right, a Raman mapping of the calcification, which was captured by a technique that detect
Oncology January 08,2024
Microcalcification 'fingerprints' can yield info about cancer

Microcalcification 'fingerprints' can yield info about cancer

byCornell UniversityLeft, a pathology stain of a ductal carcinoma, showing cells and connective tissue. Right, a Raman mapping of the calcification, which was captured by a technique that detect
Oncology January 08,2024
Fine-tuning 3D lab-grown mini tumors to help predict how patients respond to cancer therapies

Fine-tuning 3D lab-grown mini tumors to help predict how patients respond to cancer therapies

byUniversity of California, Los AngelesCredit: Pixabay/CC0 Public DomainScientists from the UCLA Jonsson Comprehensive Cancer Center have developed a new method to bioprint miniature tumor organ
Oncology January 08,2024
Fine-tuning 3D lab-grown mini tumors to help predict how patients respond to cancer therapies

Fine-tuning 3D lab-grown mini tumors to help predict how patients respond to cancer therapies

byUniversity of California, Los AngelesCredit: Pixabay/CC0 Public DomainScientists from the UCLA Jonsson Comprehensive Cancer Center have developed a new method to bioprint miniature tumor organ
Oncology January 08,2024
Minimally invasive surgery may be good option for people with pancreatic cancer

Minimally invasive surgery may be good option for people with pancreatic cancer

by Dennis ThompsonMinimally invasive surgery works just as well as full-scale open surgery in removing early-stage pancreatic cancers, allowing patients a faster recovery with less infection risk, a n
Oncology January 08,2024
Minimally invasive surgery may be good option for people with pancreatic cancer

Minimally invasive surgery may be good option for people with pancreatic cancer

by Dennis ThompsonMinimally invasive surgery works just as well as full-scale open surgery in removing early-stage pancreatic cancers, allowing patients a faster recovery with less infection risk, a n
Oncology January 08,2024
Tennis legend Martina Navratilova diagnosed with throat, breast cancer

Tennis legend Martina Navratilova diagnosed with throat, breast cancer

by Cara Murez HealthDay ReporterTennis legend Martina Navratilova, who won 59 grand slam titles in her career, announced Monday that she has both stage 1 breast cancer and throat cancer.Navratilova, 6
Oncology January 08,2024
Tennis legend Martina Navratilova diagnosed with throat, breast cancer

Tennis legend Martina Navratilova diagnosed with throat, breast cancer

by Cara Murez HealthDay ReporterTennis legend Martina Navratilova, who won 59 grand slam titles in her career, announced Monday that she has both stage 1 breast cancer and throat cancer.Navratilova, 6
Oncology January 08,2024
Guideline updated for initial management of advanced prostate cancer

Guideline updated for initial management of advanced prostate cancer

by Elana GotkineFor patients with noncastrate advanced prostate cancer, docetaxel, abiraterone, enzalutamide, apalutamide, or darolutamide are each recommended as standards of care with androgen depri
Oncology January 08,2024
Guideline updated for initial management of advanced prostate cancer

Guideline updated for initial management of advanced prostate cancer

by Elana GotkineFor patients with noncastrate advanced prostate cancer, docetaxel, abiraterone, enzalutamide, apalutamide, or darolutamide are each recommended as standards of care with androgen depri
Oncology January 08,2024
Combination cancer therapies can shrink tumors and improve outcome in advanced non-small lung cancer: Clinical trial

Combination cancer therapies can shrink tumors and improve outcome in advanced non-small lung cancer: Clinical trial

byYale UniversityCredit: Pixabay/CC0 Public DomainWhile pembrolizumab is an approved treatment for patients with stage III non-small cell lung cancer (NSCLC), only some patients respond to this
Oncology January 08,2024
Combination cancer therapies can shrink tumors and improve outcome in advanced non-small lung cancer: Clinical trial

Combination cancer therapies can shrink tumors and improve outcome in advanced non-small lung cancer: Clinical trial

byYale UniversityCredit: Pixabay/CC0 Public DomainWhile pembrolizumab is an approved treatment for patients with stage III non-small cell lung cancer (NSCLC), only some patients respond to this
Oncology January 08,2024
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com